Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000010

Chief Medical Officer acquired 6,348 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2025-02-12 Option exercise +6,348 $1.08 $6,856 164,520 D
Derivatives
Rodman David Malcom Chief Medical Officer 2025-02-12 Option exercise · Stock Option −6,348 122,229 D
Loading xslF345X05/wk-form4_1739485768.xml…